Skip to main content
SpringerLink
Log in

Study of Cardiac Receptor Ligands by Positron Emission Tomography

  • Chapter
Book cover Cardiac Positron Emission Tomography

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 166))

Abstract

Changes in receptor populations may be early markers of disease, or indicators of the therapeutic success. A large research effort is therefore directed towards tomographic imaging of receptors and quantitative interpretation of these images in terms of receptor densities. Before human studies are possible, putative receptorbinding radiotracers should be thoroughly tested.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Eckelman WC. The testing of putative receptor binding radiotracers in vivo. In: Diksic M, Reba RC, editors. Radiopharmaceuticals and brain pathology studied with PET and SPECT. Boca Raton, FL: CRC Press, 1991: 41–68.

    Google Scholar 

  2. Eckelman WC. The application of receptor theory to receptor-binding and enzyme-binding oncologic radiopharmaceuticals. Nucl Med Biol 1994;21:759–769.

    Article  PubMed  CAS  Google Scholar 

  3. Cramb G. Selective lysosomal uptake and accumulation of the ß-adrenergic antagonist propranolol in cultured and isolated cell systems. Biochem Pharmacol 1986;35:1365–1372.

    Article  PubMed  CAS  Google Scholar 

  4. Syrota A. Investigation of myocardial receptors by PET in heart diseases. In: Heiss WD, editors. Clinical Efficacy of Positron Emission Tomography. Dordrecht: Martinus Nijhoff, 1987:253–263.

    Chapter  Google Scholar 

  5. Scatchard G. The attractions of proteins for small molecules and ions. Ann N Y Acad Sci 1949;51:660–672.

    Article  CAS  Google Scholar 

  6. Gibson RE, Eckelman WC, Rzeszotarski WJ et al. Radiotracer localization by ligand-receptor interactions. In: Colombetti LG, editor. Principles of Radiopharmacology, Volume 2. West Palm Beach, FL: CRC Press, 1979:7–40.

    Google Scholar 

  7. Hellenbrecht D, Lemmer B, Wiethold G, Grobecker H. Measurement of hydrophobicity, surface activity, local anaesthesia and myocardial conduction velocity as quantitative parameters of the nonspecific membrane affinity of nine ß-adrenergic blocking agents. Naunyn Schmiedebergs Arch Pharmacol 1973;277:211–226.

    Article  PubMed  CAS  Google Scholar 

  8. Bylund DB, Charness ME, Snyder SH. Beta adrenergic receptor labeling in intact animals with 126I-hydroxybenzylpindolol. J Pharmacol Exp Ther 1977, 201:644–653.

    PubMed  CAS  Google Scholar 

  9. Hughes B, Bergmann SR, Corr PB, Sobel BE. External detection of ß-adrenoreeeptors with 126I-hydroxybenzylpindolol in isolated perfused hearts. Nucl Med Biol 1986; 13:565–571.

    CAS  Google Scholar 

  10. Homey CJ, Strauss HW, Kopiwoda S. Beta receptor occupancy: assessment in the intact animal. J Clin Invest 1980;65:1111–1118.

    Article  Google Scholar 

  11. Eckelman WC, Gibson RE, Vieras F, Rzeszotarski WJ, Francis BE, Reba RC. In vivo receptor binding of iodinated ß-adrenoceptor blockers. J Nucl Med 1980;21:436–442.

    PubMed  CAS  Google Scholar 

  12. Barnes PJ, Karliner JS. In vivo identification and distribution of α-and ß-adrenoceptors in rat heart and lung. Pharmacology 1982, 24:321–327.

    Article  PubMed  CAS  Google Scholar 

  13. Hughes B, Marshall DR, Sobel BE, Bergmann SR. Characterization of ß-adrenoreceptors in vivo with iodine-131 pindolol and gamma scintigraphy. J Nucl Med 1986;27:660–667.

    PubMed  CAS  Google Scholar 

  14. Berger G, Mazihère M, Prenant C, Sastre J, Syrota A, Cornar D. Synthesis of 11C-propranolol. J Radioanal Chem 1982;74:301–304.

    Article  CAS  Google Scholar 

  15. Antoni G, Uhlin J, Långström B. Synthesis of the 11C-labelled ß-adrenergic receptor ligands atenolol, metoprolol and propranolol. Appi Radiat Isot 1989;40:561–564.

    Article  CAS  Google Scholar 

  16. Syrota A. Positron Emission Tomography: Evaluation of cardiac receptors. In: Marcus ML, eds. Cardiac Imaging. Philadelphia, PA: W.B.Saunders, 1991:1256–1270.

    Google Scholar 

  17. Van Waarde A, Meeder JG, Blanksma PK et al. Suitability of CGP12177 and CGP26505 for quantitative imaging of ß-adrenoceptors. Nucl Med Biol 1992;19:711–718.

    Google Scholar 

  18. Van Waarde A, Meeder JG, Blanksma PK et al. Uptake of radioligands by rat heart and lung in vivo: CGP12177 does and CGP26505 does not reflect binding to ß-adrenoceptors. Eur J Pharmacol 1992;222:107–112.

    Article  PubMed  Google Scholar 

  19. Elsinga PH, Van Waarde A, Visser GM, Vaalburg W. Synthesis and preliminary evaluation of (R,S)-1-[2-((carbamoyl-4-hydroxy)phenoxy)-ethylamino]-3-[4-(1-11C-methyl-4-trifluoromethyl-2-imidazolyl) phenoxy]-2-propanol (11C-CGP 20712A) as a selective ß1adrenoceptor ligand for PET. Nucl Med Biol 1994;21:211–217.

    Article  PubMed  CAS  Google Scholar 

  20. Van Waarde A, Elsinga PH, Brodde OE, Visser GM, Vaalburg W. Myocardial and pulmonary uptake of S-1′-18F-fluorocarazolol in intact rats reflects radioligand binding to ß-adrenoceptors. Eur J Pharmacol 1995;(in press).

    Google Scholar 

  21. Law MP. Demonstration of the suitability of CGP 12177 for in vivo studies of ß-adrenoceptors. Br J Pharmacol 1993; 109:1101–1109.

    Article  PubMed  CAS  Google Scholar 

  22. Nanoff C, Freissmuth M, Schutz W. The role of a low ß1adrenoceptor selectivity of 3H-CGP-12177 for resolving subtype-selectivity of competitive ligands. Naunyn Schmiedebergs Arch Pharmacol 1987;336:519–525.

    Article  PubMed  CAS  Google Scholar 

  23. Sisson JC, Wieland DM, Koeppe RA et al. Scintigraphic portrayal of ß-receptors in the heart. J Nucl Med 1991;32:1399–1407.

    PubMed  CAS  Google Scholar 

  24. Björnerheim R, Golf S, Hansson V. Specific non-ß-adrenergic binding sites for 126l-iodocyanopindolol in myocardial membrane preparations: a comparative study between human, rat, and porcine hearts. Cardiovasc Res 1991;25:764–773.

    Article  PubMed  Google Scholar 

  25. Raffel DM, Holden JE, De Jesus OT, Endres CJ, Pooley RA. Plasma free fraction as determinant of in vivo vs in vitro equilibrium dissociation constants of receptor binding ligands: Direct experimental validation. J Nucl Med 1991;32:1004–1005 (Abstract).

    Google Scholar 

  26. Kerry R, Scrutton MC. Binding of 3H-dihydroalprenolol and 3H-acetobutolol to human blood platelets is not related to occupancy of ß-adrenoceptors. Thromb Res 1983;29:583.

    Article  PubMed  CAS  Google Scholar 

  27. Krawietz W, Erdmann E. Specific and nonspecific binding of 3H-dihydroalprenolol to cardiac tissue. Biochem Pharmacol 1979;28:1283–1288.

    Article  PubMed  CAS  Google Scholar 

  28. Dax EM, Partilla JS, Gregerman Rl. The (-) 3H-dihydroalprenolol binding to rat adipocyte membranes: an explanation of curvilinear Scatchard plots and implications for quantitation of ß-adrenoceptors. J Lipid Res 1982;23:1001–1007.

    PubMed  CAS  Google Scholar 

  29. Dax EM, Partilla JS, Gregerman RI. Quantitation of ß-adrenergic receptors in liver membranes with ß-adrenergic antagonists: only stereospecific displacement defines the ß-receptor. J Recept Res 1981;2:267–283.

    PubMed  CAS  Google Scholar 

  30. O’Hara N, Brodde OE. Identical properties of (±) and (-) 125I-iodocyanopindolol to ß2-adrenoceptors in intact human lymphocytes. Arch Int Pharmacodyn Ther 1984;272:24–39.

    PubMed  Google Scholar 

  31. Berridge MS, Cassidy EH, Terris AH, Vesselle JM. Preparation and in vivo binding of 11C-carazolol, a radiotracer for the ß-adrenergic receptor. Nucl Med Biol 1992;19:563–569.

    CAS  Google Scholar 

  32. Berridge MS, Nelson AD, Zheng LB, Leisure GP, Mirald i F. Specific ß-adrenergic receptor binding of carazolol measured with PET. J Nucl Med 1994;35:1665–1676.

    PubMed  CAS  Google Scholar 

  33. Zheng LB, Berridge MS, Ernsberger P. Synthesis, binding properties, and 18F labeling of fluorocarazolol, a high-affinity ß-adrenergic receptor antagonist. J Med Chem 1994;37:3219–3230.

    Article  PubMed  CAS  Google Scholar 

  34. Seto M, Syrota A, Crouzel C et al. Beta-adrenergic receptors in the dog heart characterized by 11C-CGP12177 and PET. J Nucl Med 1986;27:949 (Abstract).

    Google Scholar 

  35. Delforge J, Syrota A, Lançon JP et al. Cardiac ß-adrenergic receptor density measured in vivo using PET, CGP 12177, and a new graphical method. J Nucl Med 1991;32:739–748.

    PubMed  CAS  Google Scholar 

  36. Delforge J, Nakajima K, Syrota A et al. PET investigation of ß-adrenergic receptors using CGP12177. J Nucl Med 1989;30:825 (Abstract).

    Google Scholar 

  37. Mazière B, Cantineau R, Coenen HH et al. PET radiopharmaceutical metabolism — plasma metabolite analysis. In: Stöcklin G, Pike VW, editors. Radiopharmaceuticals for Positron Emission Tomography, Methodological Aspects. Dordrecht: Kluwer Academic Publishers, 1993:151–178.

    Google Scholar 

  38. Jones HA, Rhodes CG, Law MP et al. Rapid analysis for metabolites of 11C-labelled drugs: fate of 11C-S-4-(tert.-butylamino-2-hydroxypropoxy)-benzimidazol-2-one in the dog. J Chromatogr 1991;570:361–370.

    Article  PubMed  CAS  Google Scholar 

  39. Luthra SK, Osman S, Steel CJ et al. Comparison of S-11C-CGP12177 metabolism in rat, dog and man using solid phase extraction and HPLC. J Label Comp Radiopharm 1992;31:518–520 (Abstract).

    Google Scholar 

  40. Van Waarde A, Anthonio RL, Visser TJ et al. Quantification of a carbon-11-labelled ß-adrenoceptor ligand, S-(-)-CGP 12177, in plasma of humans and rats. J Chromatogr 1995;(in press).

    Google Scholar 

  41. Elsinga PH, Van Waarde A, Vos MG et al. PET imaging of pulmonary ß-adrenoceptors with S-18F-fluorocarazolol. J Nucl Med 1994;35:257P (Abstract).

    Google Scholar 

  42. Elsinga PH, Vos MG, Braker AH et al. Improved synthesis and evaluation of (S,S)-and (S,R)-18F-fluorocarazolol, ligands for the visualization of ß-adrenergic receptors. J Label Comp Radiopharm 1994;35:148–149 (Abstract).

    Google Scholar 

  43. Van Waarde A, Elsinga PH, Anthonio RL et al. Quantification of a fluorine-18-labelled ß-adrenoceptor ligand, S-1′-18F-fluorocarazolol, in plasma of humans, rats and sheep. J Chromatogr 1995;(ms in preparation).

    Google Scholar 

  44. Valette H, Delforge J, Merlet P, Crouzel C, Fuseau C, Syrota A. Up-regulation of myocardial ß-adrenergic receptors early after sympathetic chemical denervation in dogs assessed with PET and C-11 CGP 12177. J Nucl Med 1993;34:45P–46P (Abstract).

    Google Scholar 

  45. Merlet P, Dubois-Randé JL, Adnot S et al. Myocardial ß-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 1992; 19:10–16.

    Article  PubMed  CAS  Google Scholar 

  46. Merlet P, Delforge J, Syrota A et al. Positron emission tomography with 11C-CGP-12177 to assess ß-adrenergic receptor concentration in idiopathic dilated cardiomyopathy. Circulation 1993;87:1169–78.

    Article  PubMed  CAS  Google Scholar 

  47. Lefroy DC, De Silva R, Choudhury L et al. Myocardial ß-adrenoceptor density is reduced in hypertrophic cardiomyopathy. Circulation 1992;86:l–246 (Abstract).

    Google Scholar 

  48. Lefroy DC, De Silva R, Choudhury L et al. Diffuse reduction of myocardial ß-adrenoceptors in hypertrophic cardiomyopathy: a study with positron emission tomography. J Am Coll Cardiol 1993;22:1653–1660.

    Article  PubMed  CAS  Google Scholar 

  49. Qing F, Sriskandan S, Rhodes CG et al. Alveolar ß-adrenergic receptor density in asthmatic subjects before and during corticosteroid and ß-agonist therapy: preliminary studies using positron emission tomography (PET) and 11C-S-CGP12177. Thorax 1992, 47:871 (Abstract).

    Google Scholar 

  50. Robberecht P, Delhaye M, Taton G et al. The human heart ß-adrenergic receptors. I. Heterogeneity of the binding sites: presence of 50% ß1 and 50% ß2-adrenergic receptors. Mol Pharmacol 1983;24:169–173.

    PubMed  CAS  Google Scholar 

  51. Abrahamsson T, Ek B, Nerme V. The ß1 and ß2-adrenoceptor affinity of atenolol and metoprolol. A receptor-binding study performed with different radioligands in tissues from the rat, the guinea pig and man. Biochem Pharmacol 1988;37:203–208.

    Article  PubMed  CAS  Google Scholar 

  52. Raffel DM. In vivo receptor pharmacology studies with ß-adrenergic receptors in isolated perfused rat heart. University of Wisconsin, Madison WI:PhD thesis, 1991:1–219.

    Google Scholar 

  53. Staehelin M, Simons P, Jaeggi K, Wigger N. CGP-12177. A hydrophilic ß-adrenergic receptor radioligand reveals high affinity binding of agonists to intact cells. J Biol Chem 1983;258:3496–502.

    PubMed  CAS  Google Scholar 

  54. Engel G, Hoyer D, Berthold R, Wagner H. (±) 126lodocyanopindolol, a new ligand for ß-adrenoceptors: Identification and quantitation of subclasses of ß-adrenoceptors in guinea pig. Naunyn Schmiedebergs Arch Pharmacol 1981;317:277–285.

    Article  PubMed  CAS  Google Scholar 

  55. Bertaux M, Brutesco C, Loc’h C, Valette H, Mazière B. Preparation of 123I-iododenopamine: A potential radiotracer for myocardial ß-adrenergic receptor studies. J Label Comp Radiopharm 1992;31:533–534 (Abstract).

    Google Scholar 

  56. Du J, Jin X, Yuan S. Preparation of 123I-labeled metoprolol with iodine monochloride process. 10th Int Symp Radiopharm Chem, Kyoto 1993;226 (Abstract).

    Google Scholar 

  57. Juberg EN, Minneman KP, Abel PW. ß1 and ß2-adrenoceptor binding and functional response in right and left atria of rat heart. Naunyn Schmiedebergs Arch Pharmacol 1985;330:193–202.

    Article  PubMed  CAS  Google Scholar 

  58. Tondo L, Conway PG, Brunswick DJ. Labeling in vivo of ß-adrenergic receptors in the central nervous system of the rat after administration of 126I-iodopindolol. J Pharmacol Exp Ther 1985;235:1–9.

    PubMed  CAS  Google Scholar 

  59. Harada S, Ban T, Fujita T, Koshiro A. Negative inotropic effects and the hydrophobicity of ß-adrenergic blocking agents. Arch Int Pharmacodyn Ther 1981;252:262–271.

    PubMed  CAS  Google Scholar 

  60. Agon P, Goethals P, Van Haver D, Kaufman JM. Permeability of the blood-brain barrier for atenolol studied by positron emission tomography. J Pharm Pharmacol 1991;43:597–600.

    Article  PubMed  CAS  Google Scholar 

  61. Kaumann AJ, Lemoine H. Direct labelling of myocardial ß1-adrenoceptors. Comparison of binding affinity of 3H-(-)-bisoprolol with its blocking potency. Naunyn Schmiedebergs Arch Pharmacol 1985;331:27–39.

    Article  PubMed  CAS  Google Scholar 

  62. Recanatini M. Partition and distribution coefficients of aryloxypropanolamine ß-adrenoceptor antagonists. J Pharm Pharmacol 1992;44:68–70.

    Article  PubMed  CAS  Google Scholar 

  63. Ueki J, Rhodes CG, Hughes JMB et al. In vivo quantification of pulmonary ß-adrenoceptor density in humans with (S)-11C-CGP-12177 and PET. J Appl Physiol 1993;75:559–565.

    PubMed  CAS  Google Scholar 

  64. Borea PA, Amerini S, Masini I et al. ß1-and ß2-adrenoceptors in sheep cardiac ventricular muscle. J Mol Cell Cardiol 1992;24:753–763.

    Article  PubMed  CAS  Google Scholar 

  65. Pauwels PJ, Leysen JE, Janssen PA. ß-Adrenoceptor-mediated cAMP accumulation in cardiac cells: effects of nebivolol. Eur J Pharmacol 1989; 172:471–479.

    Article  PubMed  CAS  Google Scholar 

  66. Dooley DJ, Bittiger H, Reymann NC. CGP 20712 A: a useful tool for quantitating ß1 and ß2-adrenoceptors. Eur J Pharmacol 1986; 130:137–139.

    Article  PubMed  CAS  Google Scholar 

  67. Kinsey BM, Barber R, Tewson TJ. Synthesis of fluorine-18 fluorocarazolol: A ligand for the ß-adrenergic receptor. J Label Comp Radiopharm 1992;31:298–300 (Abstract).

    Google Scholar 

  68. De Groot TJ, Van Waarde A, Elsinga PH, Visser GM, Brodde OE, Vaalburg W. Synthesis and evaluation of 1’-18F-fluorometoprolol as a potential tracer for the visualization of ß-adrenoceptors with PET. Nucl Med Biol 1993;20:637–642.

    Article  PubMed  Google Scholar 

  69. Wahlund G, Nerme V, Abrahamsson T, Sjöquist PO. The ß1 and ß2-adrenoceptor affinity and ß1blocking potency of S-and R-metoprolol. Br J Pharmacol 1990;99:592–596.

    Article  PubMed  CAS  Google Scholar 

  70. Prenant C, Sastre J, Crouzel C, Syrota A. Synthesis of 11C-pindolol. J Label Comp Radiopharm 1987;24:227–232.

    Article  CAS  Google Scholar 

  71. Wuppermann D, Zimmermann F, Friedrich L. Vergleich der Wirksamkeit von Alprenolol, Bunitrolol, Ethaverin, Oxprenolol, Papaverin, Practolol, Pindolol, Pronethalol, Propranolol, Toliprolol und Verapamil auf die ß-Rezeptoren des Herzens und Bronchialsystems. Arzneimittelforschung 1978;28:794–798.

    PubMed  CAS  Google Scholar 

  72. Barnett DB, Rugg EL, Nahorski SL. Direct evidence of two types of ß-adrenoceptor binding site in lung tissues. Nature 1978;273:166–168.

    Article  PubMed  CAS  Google Scholar 

  73. Hellenbrecht D, Enenkel J. Estimation of the nonspecific cardiovascular toxicity of ß-adrenoceptor blocking drugs with different hydrophobic properties in the cat. Arzneimittelforschung 1984;34:980–983.

    PubMed  CAS  Google Scholar 

  74. Berger G, Prenant C, Sastre J, Syrota A, Cornar D. Synthesis of a ß-blocker for heart visualization: 11C-practolol. Appl Radiat Isot 1983;34:1556–1557.

    Article  CAS  Google Scholar 

  75. Tsuchihashi H, Nakashima Y, Kinami J, Nagatomo T. Characteristics of 126I-iodocyanopindolol binding to ß-adrenergic and serotonin-1B receptors of rat brain: selectivity of ß-adrenergic agents. Jpn J Pharmacol 1990;52:195–200.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Aren van Waarde
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip H. Elsinga
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rutger L. Anthonio
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ton J. Visser
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paul K. Blanksma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Gerben M. Visser
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Anne M. J. Paans
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Willem Vaalburg
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Cardiology, University Hospital Leiden, Leiden, The Netherlands

    E. E. van der Wall

  2. Department of Cardiology, University Hospital Groningen, Groningen, The Netherlands

    P. K. Blanksma

  3. Department of Cardiology, Martini Hospital, Groningen, The Netherlands

    M. G. Niemeyer

  4. PET Centre, University Hospital Groningen, Groningen, The Netherlands

    A. M. J. Paans

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

van Waarde, A. et al. (1995). Study of Cardiac Receptor Ligands by Positron Emission Tomography. In: van der Wall, E.E., Blanksma, P.K., Niemeyer, M.G., Paans, A.M.J. (eds) Cardiac Positron Emission Tomography. Developments in Cardiovascular Medicine, vol 166. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-0023-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-0023-6_15

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4014-3

  • Online ISBN: 978-94-011-0023-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation